Supira Medical
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) for high-risk patients undergoing interventional procedures and experiencing cardiogenic shock. The pVAD supports cardiovascular function during procedures and in cases of cardiogenic shock, a high-mortality condition. Supira's technology aims to improve clinical outcomes for these patients.
Buy Funded Startups lists
Funding Round: Series E
Funding Amount: $120M
Date: 26-Mar-2025
Investors: Novo Holdings, Qatar Investment Authority (QIA), two undisclosed strategic investors, Cormorant Asset Management, The Capital Partnership (TCP), 415 Capital, AMED Ventures, PA MedTech VC fund, Unorthodox Ventures
Markets: Medtech, Cardiovascular Devices
HQ: LOS GATOS, California, United States
Founded: 2012
Website: https://www.supiramedical.com/
Leave a Comment
Comments
No comments yet.